Urine hormone test for uterine cancer risk in abnormal bleeding
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at hormones in your urine to learn more about how uterine cancer develops in people with abnormal uterine bleeding. It may help find new ways to detect risk or catch problems earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 35 years old or older.
- You must have had abnormal uterine bleeding (unusual or irregular bleeding from the uterus).
- You cannot be pregnant or become pregnant during the study.
- You cannot have had surgery that affects your menstrual cycle, such as removal of the uterus (hysterectomy) or both ovaries.
- You cannot be on, or have recently taken (in the last 3 months), medications that affect hormones or ovulation, like birth control pills, hormone replacement, or fertility drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a risk model to detect endometrial cancer in people with unexplained abnormal uterine bleeding. It aims to find better ways to identify cancer early without relying only on invasive biopsies.
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study looks at how blood flow in the uterus may relate to endometrial cancer. It may help researchers understand the disease better and guide future care.
This study is testing a new way to find ovarian cancer early. It uses a gentle washing of the uterus (like a Pap test) to collect cells and look for signs of cancer in women who are at high risk because of a BRCA gene mutation. The goal is to see if this method can detect cancer before it spreads, which might help save more lives.
This study tests a new urine test that may help find cancers of the urinary tract (like bladder or kidney cancer) in people who have blood in their urine. If the test works well, it could provide a simpler way to check for cancer compared to standard procedures.
Hear when a new Uterine Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.